Sonoma Pharmaceuticals, Inc. (SNOA)

NASDAQ: SNOA · Real-Time Price · USD

1.280

+0.020 (1.59%)

At close: Sep 18, 2026, 4:00 PM EDT

1.260

-0.020 (-1.56%)

After-hours: Sep 18, 2026, 6:25 PM EDT

Sonoma Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	21.92	19.53	14.29	12.74	13.27	12.63
Revenue Growth	47.00%	36.68%	12.20%	-4.05%	5.10%	-32.21%
Gross Profit	8.53	7.42	5.47	4.75	4.48	3.99
Operating Income	-1.41	-2.46	-3.71	-4.7	-4.57	-5.89
Net Income	-2.26	-3.18	-3.46	-4.84	-5.15	-5.09
Earnings Per Share	-1.01	-1.89	-2.79	-10.63	-30.35	-38.34
EPS Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
United States	7.1	5.67	2.61	3.06	3.43	3.81
Europe	7.4	6.9	5.52	4.78	4.05	3.41
Asia	3.15	2.9	2.32	2.3	2.45	2.35
Latin America	2.44	2.37	2.96	1.73	2.38	2.1
Rest of The World	1.84	1.68	0.88	0.87	0.96	0.97
Total	21.92	19.53	14.29	12.74	13.27	12.63

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	5.34	2.4	5.37	3.13	3.82	7.4
Total Debt	0.74	0.84	0.31	0.61	0.85	1.37
Net Cash (Debt)	4.6	1.56	5.07	2.52	2.97	6.03
Net Cash Growth	56.96%	-69.28%	101.15%	-15.18%	-50.72%	290.23%
Net Cash Per Share	2.06	0.92	4.08	5.54	17.51	45.45

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-2.57	-3.93	-0.09	-2.4	-6.15	-4.25
Capital Expenditures	-0.09	-0.19	-0.08	-0	-0.27	-0.14
Free Cash Flow	-2.66	-4.13	-0.17	-2.4	-6.42	-4.39
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	38.91%	37.97%	38.25%	37.26%	33.73%	31.62%
Operating Margin	-6.41%	-12.60%	-25.97%	-36.91%	-34.43%	-46.62%
Pretax Margin	-11.44%	-17.51%	-20.35%	-39.51%	-39.06%	-42.90%
Profit Margin	-10.33%	-16.26%	-24.20%	-37.97%	-38.81%	-40.28%
FCF Margin	-12.11%	-21.12%	-1.18%	-18.85%	-48.38%	-34.72%

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 20, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Forward PE	-	11.93	11.93	11.93	11.93	11.93
PS Ratio	0.28	0.19	0.25	0.20	0.34	0.98